Search
for
Sort by
Research 121–150 of 642
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- COVID-19 and Sex Differences
- Testosterone therapy for transgender men
- Extraskeletal actions of vitamin D
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Obesity and polycystic ovary syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Health and fertility in World Health Organization group 2 anovulatory women
- What causes hidradenitis suppurativa ?—15 years after
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- PCOS in adolescents
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Mood disorders and quality of life in polycystic ovary syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review